Brackmann Christoph 4
4 · NovoCure Ltd · Filed Jul 30, 2025
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Brackmann Christoph
Chief Financial Officer
Transactions
- Purchase
Ordinary Shares
2025-07-29$11.63/sh+10,000$116,300→ 131,150 total - Purchase
Ordinary Shares
2025-07-29$11.60/sh+5,000$58,000→ 136,150 total - Purchase
Ordinary Shares
2025-07-29$11.50/sh+5,000$57,500→ 141,150 total